When Choosing a CDMO For Your Organization, Failure Is Never An Option

For today’s drug companies, especially smaller biotech companies faced with limited financial resources, expertise, people and equipment, it is of critical importance to select the appropriate CDMO outsourcing partner. They can provide vital support by helping to manage processes and facilitate creative decision-making during the early development period. But finding the right CDMO can be a challenging, time-intensive process. Within this article Peter Soelkner, Vetter Managing Director provides guidance with this process by providing answers to commonly asked questions.